126 related articles for article (PubMed ID: 28895944)
1. Genome wide in vivo mouse screen data from studies to assess host regulation of metastatic colonisation.
van der Weyden L; Karp NA; Swiatkowska A; Adams DJ; Speak AO
Sci Data; 2017 Sep; 4():170129. PubMed ID: 28895944
[TBL] [Abstract][Full Text] [Related]
2. A Genome-Wide Screen in Mice To Identify Cell-Extrinsic Regulators of Pulmonary Metastatic Colonisation.
van der Weyden L; Swiatkowska A; Iyer V; Speak AO; Adams DJ
G3 (Bethesda); 2020 Jun; 10(6):1869-1877. PubMed ID: 32245826
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary metastatic colonisation and granulomas in NOX2-deficient mice.
van der Weyden L; Speak AO; Swiatkowska A; Clare S; Schejtman A; Santilli G; Arends MJ; Adams DJ
J Pathol; 2018 Nov; 246(3):300-310. PubMed ID: 30062795
[TBL] [Abstract][Full Text] [Related]
4. A genome-wide shRNA screen identifies GAS1 as a novel melanoma metastasis suppressor gene.
Gobeil S; Zhu X; Doillon CJ; Green MR
Genes Dev; 2008 Nov; 22(21):2932-40. PubMed ID: 18981472
[TBL] [Abstract][Full Text] [Related]
5. Identification of metastasis-related genes by genomic and transcriptomic studies in murine melanoma.
Kadioglu O; Saeed MEM; Mahmoud N; Hussein Azawi SS; Rincic M; Liehr T; Efferth T
Life Sci; 2021 Feb; 267():118922. PubMed ID: 33358905
[TBL] [Abstract][Full Text] [Related]
6. Identification of genes differentially expressed in B16 murine melanoma sublines with different metastatic potentials.
Ishiguro T; Nakajima M; Naito M; Muto T; Tsuruo T
Cancer Res; 1996 Feb; 56(4):875-9. PubMed ID: 8631027
[TBL] [Abstract][Full Text] [Related]
7. A high-throughput in vivo screening method in the mouse for identifying regulators of metastatic colonization.
Speak AO; Swiatkowska A; Karp NA; Arends MJ; Adams DJ; van der Weyden L
Nat Protoc; 2017 Dec; 12(12):2465-2477. PubMed ID: 29095442
[TBL] [Abstract][Full Text] [Related]
8. Metastatic phenotype in hybrid cells derived from B16 melanoma.
Ito M; Izuhara M; Shimizu K; Sekiguchi M
Cancer Lett; 1994 Apr; 78(1-3):33-9. PubMed ID: 8180966
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid receptor knockdown decreases the antioxidant protection of B16 melanoma cells: an endocrine system-related mechanism that compromises metastatic cell resistance to vascular endothelium-induced tumor cytotoxicity.
Obrador E; Valles SL; Benlloch M; Sirerol JA; Pellicer JA; Alcácer J; Coronado JA; Estrela JM
PLoS One; 2014; 9(5):e96466. PubMed ID: 24802641
[TBL] [Abstract][Full Text] [Related]
10. A truncated isoform of the protein phosphatase 2A B56gamma regulatory subunit may promote genetic instability and cause tumor progression.
Ito A; Koma Y; Watabe K; Nagano T; Endo Y; Nojima H; Kitamura Y
Am J Pathol; 2003 Jan; 162(1):81-91. PubMed ID: 12507892
[TBL] [Abstract][Full Text] [Related]
11. Syngeneic murine metastasis models: B16 melanoma.
Giavazzi R; Decio A
Methods Mol Biol; 2014; 1070():131-40. PubMed ID: 24092437
[TBL] [Abstract][Full Text] [Related]
12. Enhanced metastasis of B16 melanoma cells by unexpected elevated expression of the metastasis-associated TI-241 (LRF-1-, Jun-Fos-related) gene treated with antisense oligonucleotide.
Ishiguro T; Naito M; Hanaoka K; Nagawa H; Muto T; Tsuruo T
Clin Exp Metastasis; 1998 Feb; 16(2):179-83. PubMed ID: 9514099
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide in vivo screen identifies novel host regulators of metastatic colonization.
van der Weyden L; Arends MJ; Campbell AD; Bald T; Wardle-Jones H; Griggs N; Velasco-Herrera MD; Tüting T; Sansom OJ; Karp NA; Clare S; Gleeson D; Ryder E; Galli A; Tuck E; Cambridge EL; Voet T; Macaulay IC; Wong K; ; Spiegel S; Speak AO; Adams DJ
Nature; 2017 Jan; 541(7636):233-236. PubMed ID: 28052056
[TBL] [Abstract][Full Text] [Related]
14. Poorly metastatic tumor cell variants as primary targets of syngeneic antibody responses against murine melanoma.
Parratto NP; Odebralski JM; Kimura AK
Cancer Res; 1989 Jul; 49(14):3722-8. PubMed ID: 2736512
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the biological effects of anti-cell adhesive synthetic peptides that inhibit experimental metastasis of B16-F10 murine melanoma cells.
Humphries MJ; Yamada KM; Olden K
J Clin Invest; 1988 Mar; 81(3):782-90. PubMed ID: 3343338
[TBL] [Abstract][Full Text] [Related]
16. Intravenous administration of bone marrow-derived multipotent mesenchymal stromal cells enhances the recruitment of CD11b(+) myeloid cells to the lungs and facilitates B16-F10 melanoma colonization.
Souza LE; Almeida DC; Yaochite JN; Covas DT; Fontes AM
Exp Cell Res; 2016 Jul; 345(2):141-9. PubMed ID: 26027946
[TBL] [Abstract][Full Text] [Related]
17. Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1.
Khokha R
J Natl Cancer Inst; 1994 Feb; 86(4):299-304. PubMed ID: 8158685
[TBL] [Abstract][Full Text] [Related]
18. Modulators of intracellular Ca2+ and the calmodulin inhibitor W-7 alter the expression of metastasis-associated genes MTS1 and NM23 in metastatic variants of the B16 murine melanoma.
Parker C; Sherbet GV
Melanoma Res; 1992 Dec; 2(5-6):337-43. PubMed ID: 1337998
[TBL] [Abstract][Full Text] [Related]
19. Cyano Enone-Bearing Triterpenoid Soloxolone Methyl Inhibits Epithelial-Mesenchymal Transition of Human Lung Adenocarcinoma Cells In Vitro and Metastasis of Murine Melanoma In Vivo.
Markov AV; Odarenko KV; Sen'kova AV; Salomatina OV; Salakhutdinov NF; Zenkova MA
Molecules; 2020 Dec; 25(24):. PubMed ID: 33327637
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of new metastatic variants of B16 melanoma under different culture conditions.
Aubert C; Ali-Mehidi S; Rouge F; Voulot C
Pigment Cell Res; 1992 Feb; 5(1):12-24. PubMed ID: 1631017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
